Venetoclax and hypomethylating agents in TP53-mutated acute myeloid leukaemia.

Ibrahim AldossJianying ZhangRaju PillaiGeoffrey ShouseJames F SanchezMatthew MeiRyotaro NakamuraAnthony S SteinStephen J FormanGuido MarcucciVinod Pullarkat

Published in: British journal of haematology (2019)

Keyphrases

liver failure
respiratory failure
bone marrow
dendritic cells
acute myeloid leukemia
drug induced
aortic dissection
chronic lymphocytic leukemia
hepatitis b virus
intensive care unit
extracorporeal membrane oxygenation
mechanical ventilation